Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity. PUBMED, EMBASE, and Cochrane Library were identified on 13 May 2017 to identify relevant randomized controlled trials. All data obtained were analyze...

Full description

Bibliographic Details
Main Authors:	Shang-Jun Wu, Yu-Qiong Xu, Zheng-Yan Gao, Zhi-Peng Wang, Feng Zhao, Lin Liu, Sheng Wang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-01-01
Series:	Renal Failure
Subjects:	neurogenic detrusor overactivity botulinum toxin a urinary incontinence adverse effects meta-analysis
Online Access:	http://dx.doi.org/10.1080/0886022X.2019.1655448

Similar Items

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

FREQUENCY OF DETRUSOR LEAK POINT PRESSURES AMONGST PATIENTS WITH URODYNAMIC DIAGNOSIS OF DETRUSOR OVERACTIVITY
by: Nadeem Ahmad, et al.
Published: (2019-08-01)

Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin
by: Ana Ferreira, et al.
Published: (2023-02-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: S. Deffontaines-Rufin, et al.
Published: (2011-10-01)

Botulinum toxin injection: a review of injection principles and protocols
by: David E. Rapp, et al.
Published: (2007-04-01)

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
by: Djamel Bensmail, et al.
Published: (2023-04-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Efficacy and Safety of OnabotulinumtoxinA in Treating Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis
by: Xin Zhou, et al.
Published: (2015-01-01)

Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis
by: Hejia Yuan, et al.
Published: (2017-03-01)

Efficacy and Safety of OnabotulinumtoxinA in Patients With Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury: A Systematic Review and Meta-analysis
by: Guang-Ping Li, et al.
Published: (2018-12-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
by: Kwang Jin Ko, et al.
Published: (2019-03-01)

BOTULINUM IN MODERN UROLOGY
by: A. D. KAPRIN, et al.
Published: (2016-12-01)

Therapeutic Approaches of Botulinum Toxin in Gynecology
by: Marius Alexandru Moga, et al.
Published: (2018-04-01)

In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
by: Banakhar M, et al.
Published: (2021-09-01)

Significance of preoperatively observed detrusor overactivity as a predictor of continence status early after robot-assisted radical prostatectomy
by: Akihiro Yanagiuchi, et al.
Published: (2014-12-01)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
by: Aida Javan Balegh Marand, et al.
Published: (2023-05-01)

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia
by: Yu-Hui Huang, et al.
Published: (2022-03-01)

Short-term outcome of onabotulinumtoxin A injection for the treatment of refractory idiopathic detrusor overactivity
by: Gamal E A. Abourjila, et al.
Published: (2020-01-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
by: Yuan-Hong Jiang, et al.
Published: (2023-04-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

Role of percutaneous tibial nerve stimulation in the management of the detrusor overactivity
by: Emad K El Tair, et al.
Published: (2022-01-01)

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
by: David C. Moore, et al.
Published: (2016-03-01)

Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions
by: Yuan-Hong Jiang, et al.
Published: (2024-03-01)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
by: Sheng-Fu Chen, et al.
Published: (2022-01-01)